Cold & Cough Care
Natural health product licensed in Canada
- Licence holder
- Jensens Labs Inc.
- NPN or DIN-HM
- 80053400
- Status
- Active licence
- Licence date
- 26 August 2014
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trigonella foenum-graecum Source : Trigonella foenum-graecum-Seed | 660 mg | Not calculated |
| Thymus vulgaris Source : Sommité en fleurs (herbe) Extract : Matériel brut sec Extraction ratio : 1:5 Dry plant equivalent : 400 mg | 2 mL | Not calculated |
| Glycyrrhiza glabra Source : Racine et stolon Extract : Matériel brut sec Extraction ratio : 1:5 Dry plant equivalent : 300 mg | 1.5 mL | Not calculated |
| Angelica archangelica Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 1:5 Dry plant equivalent : 200 mg | 1 mL | Not calculated |
| Cnicus benedictus Source : Sommité Extract : Matériel brut sec Extraction ratio : 1:5 Dry plant equivalent : 900 mg | 4.5 mL | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce Source : Graine(s) | 400 mg | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 1:10 Dry plant equivalent : 200 mg | 2 mL | Not calculated |
Non-medicinal ingredients
PVP, Acide stéarique, Stéarate de magnésium, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditionally used in Herbal Medicine as an expectorant to help relieve bronchial illness, coughs and colds.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80053400
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.